EUVIMEDEUVIMED entdecken
Übersichtsarbeit

State-of-the-Art Review: Hepatitis C

Vincent Lo Re iD, Debika Bhattacharya iD, Jennifer C Price, Andrew Aronsohn, H Nina Kim iD, Oluwaseun Falade-Nwulia iD, Matty Zimmerman, Stacey Trooskin, Jessie Torgersen

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciaf334 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Vincent Lo Re und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) infection remains a major cause of chronic liver disease and premature mortality worldwide. The World Health Organization and US Department of Health and Human Services have committed to eliminating HCV infection as a major public health threat by 2030, as defined by a 90% reduction in incidence of new HCV infections and 65% reduction in mortality from a 2015 baseline. To help to achieve HCV elimination, it will be necessary to increase HCV screening and increase uptake of HCV treatment, particularly within primary care, correctional, and substance use treatment settings. In this review, we provide strategies for healthcare providers to implement in their practice to enhance patients’ completion of the steps of the HCV care cascade. Improving successful completion of each step of the cascade will help alleviate the burden of HCV infection and make the 2030 HCV elimination goals a reality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CHepatitis C, ChronicHumansAntiviral AgentsHepacivirusDisease EradicationMass Screening

Stichwörter der Autor:innen

HCV eliminationHCV infectioncascade of caredirect-acting antiviral therapyhepatitis C virus

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago Illinois, USA.
  • Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

ORCID-Profile: Vincent Lo Re, Debika Bhattacharya, H Nina Kim, Oluwaseun Falade-Nwulia

Zitieren

APA

Lo Re, V., Bhattacharya, D., Price, J. C., Aronsohn, A., Kim, H. N., Falade-Nwulia, O., Zimmerman, M., Trooskin, S., & Torgersen, J. (2025). State-of-the-Art Review: Hepatitis C. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf334

Vancouver

Lo Re V, Bhattacharya D, Price JC, Aronsohn A, Kim HN, Falade-Nwulia O, et al. State-of-the-Art Review: Hepatitis C. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf334

BibTeX
@article{LoRe2025,
  author = {Lo Re, Vincent and Bhattacharya, Debika and Price, Jennifer C and Aronsohn, Andrew and Kim, H Nina and Falade-Nwulia, Oluwaseun and Zimmerman, Matty and Trooskin, Stacey and Torgersen, Jessie},
  title = {State-of-the-Art Review: Hepatitis C},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciaf334}
}
Kostenlos starten →